Literature DB >> 11461091

Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse.

M El-Abbadi1, T N Seyfried, A J Yates, C Orosz, M C Lee.   

Abstract

Glycosphingolipid abnormalities have long been implicated in tumour malignancy and metastasis. Gangliosides are a family of sialic acid-containing glycosphingolipids that modulate cell-cell and cell-matrix interactions. Histology and ganglioside composition were examined in a natural brain tumour of the VM mouse strain. The tumour is distinguished from other metastatic tumour models because it arose spontaneously and metastasizes to several organs including brain and spinal cord after subcutaneous inoculation of tumour tissue in the flank. By electron microscopy, the tumour consisted of cells (15 to 20 microm in diameter) that had slightly indented nuclei and scant cytoplasm. The presence of smooth membranes with an absence of junctional complexes was a characteristic ultrastructural feature. No positive immunostaining was found for glial or neuronal markers. The total ganglioside sialic acid content of the subcutaneously grown tumour was low (12.6 +/- 0.9 microg per 100 mg dry wt, n = 6 separate tumours) and about 70% of this was in the form of N-glycolylneuraminic acid. In contrast, the ganglioside content of the cultured VM tumour cells was high (248.4 +/- 4.4 microg, n = 3) and consisted almost exclusively of N-acetylneuraminic acid. The ganglioside pattern of the tumour grown subcutaneously was complex, while GM3, GM2, GM1, and GD1a were the major gangliosides in the cultured tumour cells. This tumour will be a useful natural model for evaluating the role of gangliosides and other glycolipids in tumour cell invasion and metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461091      PMCID: PMC2364034          DOI: 10.1054/bjoc.2001.1909

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  57 in total

1.  In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.

Authors:  P Fredman; C J Wikstrand; J E Månsson; G Reifenberger; S H Bigner; A Rasheed; L Svennerholm; D D Bigner
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

Review 2.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

3.  Influence of host cell infiltration on the glycolipid content of mouse brain tumors.

Authors:  T N Seyfried; M el-Abbadi; J A Ecsedy; H W Bai; H C Yohe
Journal:  J Neurochem       Date:  1996-05       Impact factor: 5.372

4.  Effects of neuroblastoma tumor gangliosides on platelet adhesion to collagen.

Authors:  L H Fang; M Lucero; T Kazarian; Q Wei; F Y Luo; L A Valentino
Journal:  Clin Exp Metastasis       Date:  1997-01       Impact factor: 5.150

Review 5.  Extracranial metastasis of glioblastoma multiforme diagnosed by fine-needle aspiration: a report of two cases and a review of the literature.

Authors:  G Vural; B Hagmar; L Walaas
Journal:  Diagn Cytopathol       Date:  1996-07       Impact factor: 1.582

6.  Leptomeningeal tissue: a barrier against brain tumor cell invasion.

Authors:  P H Pedersen; G J Rucklidge; S J Mørk; A J Terzis; O Engebraaten; M Lund-Johansen; E O Backlund; O D Laerum; R Bjerkvig
Journal:  J Natl Cancer Inst       Date:  1994-11-02       Impact factor: 13.506

7.  Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer alpha 2-3 sialyltransferase (GM3 synthase).

Authors:  N Zebda; S Pedron; A Rebbaa; J Portoukalian; O Berthier-Vergnes
Journal:  FEBS Lett       Date:  1995-04-03       Impact factor: 4.124

8.  Correlation of ganglioside patterns of primary brain tumors with survival.

Authors:  C C Sung; D K Pearl; S W Coons; B W Scheithauer; P C Johnson; M Zheng; A J Yates
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

9.  Serum gangliosides in mice with metastatic and non-metastatic brain tumors.

Authors:  M Cotterchio; T N Seyfried
Journal:  J Lipid Res       Date:  1994-01       Impact factor: 5.922

10.  Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro.

Authors:  C J Wikstrand; P Fredman; R R McLendon; L Svennerholm; D D Bigner
Journal:  Mol Chem Neuropathol       Date:  1994 Feb-Apr
View more
  8 in total

1.  Assessment of the molecular expression and structure of gangliosides in brain metastasis of lung adenocarcinoma by an advanced approach based on fully automated chip-nanoelectrospray mass spectrometry.

Authors:  Alina D Zamfir; Alina Serb; Željka Vukeli; Corina Flangea; Catalin Schiopu; Dragana Fabris; Svjetlana Kalanj-Bognar; Florina Capitan; Eugen Sisu
Journal:  J Am Soc Mass Spectrom       Date:  2011-10-15       Impact factor: 3.109

2.  Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.

Authors:  Thomas N Seyfried; Purna Mukherjee
Journal:  J Oncol       Date:  2010-06-20       Impact factor: 4.375

Review 3.  Why Is N-Glycolylneuraminic Acid Rare in the Vertebrate Brain?

Authors:  Leela R L Davies; Ajit Varki
Journal:  Top Curr Chem       Date:  2015

4.  A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion.

Authors:  Laura M Shelton; Purna Mukherjee; Leanne C Huysentruyt; Ivan Urits; Joshua A Rosenberg; Thomas N Seyfried
Journal:  J Neurooncol       Date:  2010-01-13       Impact factor: 4.130

5.  Differentiating N-linked glycan structural isomers in metastatic and nonmetastatic tumor cells using sequential mass spectrometry.

Authors:  Justin M Prien; Leanne C Huysentruyt; David J Ashline; Anthony J Lapadula; Thomas N Seyfried; Vernon N Reinhold
Journal:  Glycobiology       Date:  2008-02-06       Impact factor: 4.313

6.  Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.

Authors:  Laura M Shelton; Leanne C Huysentruyt; Purna Mukherjee; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2010-07-23       Impact factor: 4.146

Review 7.  Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.

Authors:  Irina V Kholodenko; Daniel V Kalinovsky; Igor I Doronin; Sergey M Deyev; Roman V Kholodenko
Journal:  J Immunol Res       Date:  2018-07-11       Impact factor: 4.818

8.  Absence of pathogenic mitochondrial DNA mutations in mouse brain tumors.

Authors:  Michael A Kiebish; Thomas N Seyfried
Journal:  BMC Cancer       Date:  2005-08-16       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.